Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Mar;30(3):303-14.
doi: 10.1007/s00384-014-2075-8. Epub 2014 Nov 22.

Management of nodal disease from colon cancer in the laparoscopic era

Affiliations
Review

Management of nodal disease from colon cancer in the laparoscopic era

Corrado Pedrazzani et al. Int J Colorectal Dis. 2015 Mar.

Abstract

Purpose: In colon cancer (CC), nodal involvement is the main prognostic factor following potentially curative (R0) resection. The purpose of this study was to examine data from the literature to provide an up-to-date analysis of the management of nodal disease with special reference to laparoscopic treatment.

Methods: MEDLINE and EMBASE databases were searched for potentially eligible studies published in English up to July 15, 2014.

Results: In CC, nodal involvement is a frequent event and represents the main risk of cancer recurrence. Node negative patients recur in 10-30 % of cases most likely due to underdiagnosed or undertreated nodal disease. Extended colonic resections (complete mesocolic excision with central vascular ligation; D3 lymphadenectomy) provides a survival benefit and better local control. Sentinel lymph node mapping in addition to standard surgical resection represents an option for improving staging of clinical node negative patients. Both extended resection and sentinel lymph node mapping are feasible in a laparoscopic setting.

Conclusions: Both extended colonic resection and sentinel lymph node mapping should play a role in the laparoscopic treatment of CC with the purpose of improving control and staging of nodal disease.

PubMed Disclaimer

References

    1. Lancet. 2010 Mar 20;375(9719):1030-47 - PubMed
    1. Ann Surg. 2007 Oct;246(4):655-62; discussion 662-4 - PubMed
    1. Ann Surg Oncol. 2007 Jul;14(7):1980-90 - PubMed
    1. Lancet Oncol. 2009 Jan;10(1):44-52 - PubMed
    1. J Surg Res. 2013 Jul;183(1):253-7 - PubMed

LinkOut - more resources